Cargando…
KIR(+)CD8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19
In this work, we find that CD8(+) T cells expressing inhibitory killer cell immunoglobulin-like receptors (KIRs) are the human equivalent of Ly49(+)CD8(+) regulatory T cells in mice and are increased in the blood and inflamed tissues of patients with a variety of autoimmune diseases. Moreover, these...
Autores principales: | Li, Jing, Zaslavsky, Maxim, Su, Yapeng, Guo, Jing, Sikora, Michael J., van Unen, Vincent, Christophersen, Asbjørn, Chiou, Shin-Heng, Chen, Liang, Li, Jiefu, Ji, Xuhuai, Wilhelmy, Julie, McSween, Alana M., Palanski, Brad A., Mallajosyula, Venkata Vamsee Aditya, Bracey, Nathan A., Dhondalay, Gopal Krishna R., Bhamidipati, Kartik, Pai, Joy, Kipp, Lucas B., Dunn, Jeffrey E., Hauser, Stephen L., Oksenberg, Jorge R., Satpathy, Ansuman T., Robinson, William H., Dekker, Cornelia L., Steinmetz, Lars M., Khosla, Chaitan, Utz, Paul J., Sollid, Ludvig M., Chien, Yueh-Hsiu, Heath, James R., Fernandez-Becker, Nielsen Q., Nadeau, Kari C., Saligrama, Naresha, Davis, Mark M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995031/ https://www.ncbi.nlm.nih.gov/pubmed/35258337 http://dx.doi.org/10.1126/science.abi9591 |
Ejemplares similares
-
CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19
por: Mallajosyula, Vamsee, et al.
Publicado: (2021) -
Cosmochemistry
por: McSween, Harry Y, et al.
Publicado: (2010) -
Activation and Inhibition of Transglutaminase 2 in Mice
por: Dafik, Laila, et al.
Publicado: (2012) -
Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019) -
Phenotype‐Based Isolation of Antigen‐Specific CD4(+) T Cells in Autoimmunity: A Study of Celiac Disease
por: Christophersen, Asbjørn, et al.
Publicado: (2022)